elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40128798-FA1C080E-00A7-425C-B4B5-D641B6BE4EE9
Q40128798-FA1C080E-00A7-425C-B4B5-D641B6BE4EE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40128798-FA1C080E-00A7-425C-B4B5-D641B6BE4EE9
GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients.
P2860
Q40128798-FA1C080E-00A7-425C-B4B5-D641B6BE4EE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40128798-FA1C080E-00A7-425C-B4B5-D641B6BE4EE9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de0e482a29ae77d8afcd7b48bf561d13e1f32662
P2860
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.